Cargando…
Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas
BACKGROUND: Diffuse intrinsic pontine gliomas (DIPG), within diffuse midline gliomas are aggressive pediatric brain tumors characterized by histone H3-K27M mutation. Small-molecule inhibitors for the EZH2-H3K27 histone methyltransferase have shown promise in preclinical animal models of DIPG, despit...
Autores principales: | Keane, Lily, Cheray, Mathilde, Saidi, Dalel, Kirby, Caoimhe, Friess, Lara, Gonzalez-Rodriguez, Patricia, Gerdes, Maren Elisabeth, Grabert, Kathleen, McColl, Barry W, Joseph, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409254/ https://www.ncbi.nlm.nih.gov/pubmed/34485907 http://dx.doi.org/10.1093/noajnl/vdab096 |
Ejemplares similares
-
Atg7 deficiency in microglia drives an altered transcriptomic profile associated with an impaired neuroinflammatory response
por: Friess, Lara, et al.
Publicado: (2021) -
An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect
por: Rahal, Farah, et al.
Publicado: (2022) -
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
por: du Chatinier, Aimée, et al.
Publicado: (2022) -
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
por: Messinger, Dana, et al.
Publicado: (2022) -
The Rules of Engagement: Do Microglia Seal the Fate in the Inverse Relation of Glioma and Alzheimer’s Disease?
por: Cheray, Mathilde, et al.
Publicado: (2019)